Basics Inhibrx, Inc. IPO Date: August 19, 2020 Sector: Healthcare Industry: Biotech Market Cap: $543.49M Activated in VL: True Average Daily Range Avg Daily Range: $0.79 | 3.44% Avg Daily Range (30 D): $1.24 | 3.74% Avg Daily Range (90 D): $0.84 | 3.22% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): .17M Avg Daily Volume (90 D): .12M Trade Size Avg Trade Size (Sh.): 63 Avg Trade Size (Sh.) (30 D): 51 Avg Trade Size (Sh.) (90 D): 53 Institutional Trades Total Inst.Trades: 1,254 Avg Inst. Trade: $2.19M Avg Inst. Trade (30 D): $1.05M Avg Inst. Trade (90 D): $1.14M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.15M Avg Closing Trade (30 D): $1.16M Avg Closing Trade (90 D): $1.17M Avg Closing Volume: 81.8K     News Oct 24, 2025 @ 7:05 AM Why Are Inhibrx Biosciences Shares Soaring 76% Aft... Source: Mohd Haider Jul 23, 2024 @ 9:01 AM Inhibrx stock rated 'Market Perform' by JMP after ... Source: Emilio Ghigini Feb 28, 2024 @ 3:25 PM Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue... Source: Zacks Equity Research Feb 22, 2024 @ 10:15 PM BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings a... Source: Zacks Equity Research Jan 25, 2024 @ 2:26 PM Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY... Source: Kinjel Shah Financials   TTM Q1 2025 Q4 2024 Basic EPS $116.43 $-2.8 $-5.03 Diluted EPS $115.37 $-2.8 $-4.47 Revenue $ .2M $ M $ .1M Gross Profit $ $ $ Net Income / Loss $ 1.72B $ -43.31M $ -47.87M Operating Income / Loss $ -300.52M $ -42.9M $ -49.93M Cost of Revenue $ $ $ Net Cash Flow $ -35.96M $ 63.92M $ -43.74M PE Ratio 0.40